Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT03266848 · ClinicalTrials.gov registry record
Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI
A clinical trial of Cerebrovascular Disorders, sponsored by Theranano.
- Completed
- Registry status
- 15
- Enrollment target
- 1
- Study location
NCT03266848 is a study of Cerebrovascular Disorders that has completed, run by Theranano. The registered enrollment target is 15 participants, below the 1,095-participant average among 8 other Cerebrovascular Disorders trials with a reported enrollment target (99% lower). The trial reports 1 study location across 1 state.
The verdict
NCT03266848, a study of Cerebrovascular Disorders, has completed, sponsored by Theranano.
- COMPLETED
- Registry status
- 15 participants
- Enrollment target
- 1
- Study location
Study Summary
This trial will evaluate a non-invasive brain imaging technique QUTE-CE MRI and validate the method with first-in-human studies.
Conditions Studied
Interventions
- DIAGNOSTIC_TEST Quantitative Magnetic Resonance Imaging
Study Locations (1)
Massachusetts
- Massachusetts General Hospital - Boston
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 15 participants |
| Start Date | 2017-11-08 |
| Est. Completion | 2020-07-22 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT03266848
The ClinicalTrials.gov registry entry for NCT03266848 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 15 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 1,095-participant average among 8 other Cerebrovascular Disorders trials with a reported enrollment target (99% lower). The listed sponsor is Theranano, which has 1 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Cerebrovascular Disorders appearing as the primary indexed condition, and to 1 intervention - of which Quantitative Magnetic Resonance Imaging is the first listed.
NCT03266848 reports 1 study location spanning 1 distinct geographic area - top geographies include Massachusetts.
Frequently Asked Questions
What is clinical trial NCT03266848 about?
NCT03266848 is a clinical study titled "Quantitative Non-Invasive Brain Imaging Using QUTE-CE MRI". This trial will evaluate a non-invasive brain imaging technique QUTE-CE MRI and validate the method with first-in-human studies.
What is the current status of trial NCT03266848?
This trial is currently completed. The enrollment target is 15 participants. The study started on 2017-11-08. Estimated completion is 2020-07-22.
What conditions does trial NCT03266848 study?
This clinical trial studies the following conditions: Cerebrovascular Disorders.
What interventions are being tested in trial NCT03266848?
The interventions under investigation include: Quantitative Magnetic Resonance Imaging (DIAGNOSTIC_TEST).
Who is sponsoring clinical trial NCT03266848?
This trial is sponsored by Theranano, which has 1 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT03266848 being conducted?
This trial has 1 study location across Massachusetts. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Cerebrovascular Disorders
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Cerebrovascular Health and Resilience in Midlife
RECRUITING · NA
-
Inhaled Nitric Oxide in Acute Ischemic Stroke Patients Undergoing Mechanical Thrombectomy
RECRUITING · Phase 1
-
Brain, Blood And Clot or Tissue Registry And Collaboration
RECRUITING
-
The Jackson Heart Study of Cardiovascular Disease Among African Americans
ACTIVE NOT RECRUITING
-
Epidemiology of Sleep-Disordered Breathing in Adults
ACTIVE NOT RECRUITING
-
pRESET for Occlusive Stroke Treatment
COMPLETED · NA
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.